| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |